October 19, 2017 10:44 AM EDT
Outsourcing
News Briefing

Spec­trum shares spike on pre­lim­i­nary PhII can­cer da­ta; Clin­i­pace names a new CEO

John Carroll

Editor & Founder

→ One of Wednes­day’s big movers was Spec­trum Phar­ma­ceu­ti­cals $SP­PI, which tout­ed the pre­lim­i­nary re­sults from a small Phase II study of its drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

A service from the Financial Times